Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher W Crank

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Clinical Therapeutics|January 4, 2011
Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort studyChristopher W Crank, Marc H Scheetz, Benjamin Brielmaier, et al.
Clinical Therapeutics|August 4, 2010
Impact of the implementation of a sepsis protocol for the management of fluid-refractory septic shock: A single-center, before-and-after studyPayal K Gurnani, Gourang P Patel, Christopher W Crank, et al.
International Journal of Antimicrobial Agents|November 4, 2011
Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidenceDavid P Nicolau, Yehuda Carmeli, Christopher W Crank, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2015
Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infectionsSonia N Rao, Nathaniel J Rhodes, Benjamin J Lee, et al.
Pharmacotherapy|September 20, 2011
High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective studyRavina Kullar, Susan L Davis, Donald P Levine, et al.
The Journal of Antimicrobial Chemotherapy|August 10, 2013
A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditisRavina Kullar, Anthony M Casapao, Susan L Davis, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2013
Multicenter study of high-dose daptomycin for treatment of enterococcal infectionsAnthony M Casapao, Ravina Kullar, Susan L Davis, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical Therapeutics|January 4, 2011
Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort studyChristopher W Crank, Marc H Scheetz, Benjamin Brielmaier, et al.
Clinical Therapeutics|August 4, 2010
Impact of the implementation of a sepsis protocol for the management of fluid-refractory septic shock: A single-center, before-and-after studyPayal K Gurnani, Gourang P Patel, Christopher W Crank, et al.
International Journal of Antimicrobial Agents|November 4, 2011
Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidenceDavid P Nicolau, Yehuda Carmeli, Christopher W Crank, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2015
Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infectionsSonia N Rao, Nathaniel J Rhodes, Benjamin J Lee, et al.
Pharmacotherapy|September 20, 2011
High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective studyRavina Kullar, Susan L Davis, Donald P Levine, et al.
The Journal of Antimicrobial Chemotherapy|August 10, 2013
A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditisRavina Kullar, Anthony M Casapao, Susan L Davis, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2013
Multicenter study of high-dose daptomycin for treatment of enterococcal infectionsAnthony M Casapao, Ravina Kullar, Susan L Davis, et al.
Pageof 2